4//SEC Filing
ENANTA PHARMACEUTICALS INC 4
Accession 0000908662-13-000324
$ENTACIK 0001177648operating
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:34 PM ET
Size
8.5 KB
Accession
0000908662-13-000324
Insider Transaction Report
Form 4
AFTING ERNST-GUNTER
Director
Transactions
- Sale
Common Stock
2013-12-11$36.38/sh−5,800$210,990→ 26,487 total - Sale
Common Stock
2013-12-11$37.91/sh−2,100$79,622→ 17,287 total - Sale
Common Stock
2013-12-11$37.20/sh−7,100$264,111→ 19,387 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.6900 to $36.6800, inclusive.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.7100 to $37.6900, inclusive.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.8050 to $38.0200, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 above.
Documents
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeoperating
Related Parties
1- filerCIK 0001177648
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 6:34 PM ET
- Size
- 8.5 KB